| Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning P Ferdinandy, R Schulz, GF Baxter Pharmacological reviews 59 (4), 418-458, 2007 | 1024 | 2007 |
| Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? DJ Hausenloy, HL Maddock, GF Baxter, DM Yellon Cardiovascular research 55 (3), 534-543, 2002 | 798 | 2002 |
| Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning P Ferdinandy, DJ Hausenloy, G Heusch, GF Baxter, R Schulz Pharmacological reviews 66 (4), 1142-1174, 2014 | 689 | 2014 |
| Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of … M Ovize, GF Baxter, F Di Lisa, P Ferdinandy, D Garcia-Dorado, ... Cardiovascular research 87 (3), 406-423, 2010 | 644 | 2010 |
| Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injury: Evidence for a role of KATP channels D Johansen, K Ytrehus, GF Baxter Basic research in cardiology 101, 53-60, 2006 | 451 | 2006 |
| Ischaemic preconditioning: present position and future directions DM Yellon, GF Baxter, D Garcia-Dorado, G Heusch, MS Sumeray Cardiovascular research 37 (1), 21-33, 1998 | 444 | 1998 |
| A “second window of protection” or delayed preconditioning phenomenon: future horizons for myocardial protection? DM Yellon, GF Baxter Journal of molecular and cellular cardiology 27 (4), 1023-1034, 1995 | 390 | 1995 |
| Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin D Roy, J Quiles, DC Gaze, P Collinson, JC Kaski, GF Baxter Heart 92 (1), 113-114, 2006 | 387 | 2006 |
| Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels TJ Pell, GF Baxter, DM Yellon, GM Drew American Journal of Physiology-Heart and Circulatory Physiology 275 (5 …, 1998 | 381 | 1998 |
| Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. GF Baxter, MS Marber, VC Patel, DM Yellon Circulation 90 (6), 2993-3000, 1994 | 369 | 1994 |
| Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium GF Baxter, FM Goma, DM Yellon Basic research in cardiology 92, 159-167, 1997 | 324 | 1997 |
| B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening SP D'souza, DM Yellon, C Martin, R Schulz, G Heusch, A Onody, ... American Journal of Physiology-Heart and Circulatory Physiology 284 (5 …, 2003 | 320 | 2003 |
| Autocrine and paracrine actions of natriuretic peptides in the heart SP D'Souza, M Davis, GF Baxter Pharmacology & therapeutics 101 (2), 113-129, 2004 | 299 | 2004 |
| Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury MM Mocanu, GF Baxter, DM Yellon British journal of pharmacology 130 (2), 197-200, 2000 | 289 | 2000 |
| Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations DJ Hausenloy, G Baxter, R Bell, HE Břtker, SM Davidson, J Downey, ... Basic research in cardiology 105, 677-686, 2010 | 286 | 2010 |
| Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? DM Yellon, GF Baxter Heart 83 (4), 381-387, 2000 | 244 | 2000 |
| Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide MM Mocanu, HL Maddock, GF Baxter, CL Lawrence, NB Standen, ... Circulation 103 (25), 3111-3116, 2001 | 224 | 2001 |
| Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium GF Baxter, FM Goma, DM Yellon British journal of pharmacology 115 (2), 222-224, 1995 | 221 | 1995 |
| Cyclic GMP and protein kinase‐G in myocardial ischaemia‐reperfusion: opportunities and obstacles for survival signaling DS Burley, P Ferdinandy, GF Baxter British journal of pharmacology 152 (6), 855-869, 2007 | 220 | 2007 |
| Regulation of cardiovascular cell function by hydrogen sulfide (H2S) DJ Elsey, RC Fowkes, GF Baxter Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 2010 | 211 | 2010 |
Derek YellonProfessor of Molecular & Cellular CardiologyVerified email at ucl.ac.uk
